Lv1
40 积分 2025-07-16 加入
Improved survival in multiple myeloma and the impact of novel therapies
1小时前
已完结
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
1小时前
已完结
The role of CXCR4 in multiple myeloma: Cells’ journey from bone marrow to beyond
2天前
已完结
Advances in PET imaging of the CXCR4 receptor: [(68)Ga]Ga-PentixaFor
1个月前
已完结
CXCR4-targeted PET imaging in hematologic malignancies: a systematic review and meta-analysis
1个月前
已完结
Myeloablative radioligand therapy targeting C-X-C motif chemokine receptor 4 in advanced multiple myeloma
1个月前
已完结
Extramedullary relapsed multiple myeloma treatment with 177Lu-labeled CXCR4 endoradiotherapy and dosimetric results
1个月前
已完结
Chemokine receptor-4 targeted PET/CT with (68)Ga-pentixafor in assessment of newly diagnosed multiple myeloma: comparison to (18)F-FDG PET/CT
2个月前
已完结
Second generation Al(18)F-labeled D-amino acid peptide for CXCR4 targeted molecular imaging
2个月前
已完结
68 Ga-pentixafor PET/CT-based response evaluation and its prognostic value in multiple myeloma: comparison with IMWG and 18 F-FDG-based response
2个月前
已完结
皖公网安备34019202002308
